Document is current
Any future updates will be listed below
-
Authors
van Ewijk, Roelof https://orcid.org/0000-0003-0339-6031
Dandis, Rana
Rodewijk, Janna
de Keizer, Bart
ter Horst, Simone A. J.
van de Sande, Michiel A. J.
van der Heijden, Lizz
Merks, Johannes H. M.
Haveman, Lianne M.
Braat, Arthur J. A. T.
-
Funding
Funding for this research was provided by:
Stichting Prinses Máxima Centrum
- License Information
-
More Information
Article History
Received: 16 August 2024
Revised: 7 November 2024
Accepted: 21 December 2024
First Online: 24 January 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is R.E.
: A.B. acted as a consultant for Boston Scientific, Terumo, and GE Healthcare, receiving research support from Boston Scientific, Terumo, and Ariceum Therapeutics. J.M. reports personal/consulting fees from Bayer, GlaxoSmithKline, and Merck. R.E., R.D., J.R., B.K., S.H., M.S., L.v.d.H., and L.H. have no relevant financial or non-financial interests to disclose.
: One of the authors (R.D.) is a statistician.
: Data were retrospectively collected as part of the biobank and data access initiative of the institute, for which all included patients and/or their legal representatives provided signed informed consent.
: The Institutional Medical Ethics Review Board confirmed that the Medical Research Involving Human Subjects Act (WMO) did not apply to the study (research protocol number 23-207/DB).
: No study subjects or cohorts have been previously reported.
:
